First Round Capital and Chemistry led a $26m Series A round in Assort Health.

First Round Capital, a private equity firm, and Chemistry, a venture capital firm, led a $26m Series A round in Assort Health, an AI platform for managing patient phone calls, with participation from Assort Health, Four Acres, Tau Ventures, Athena Health, Astrana Health, Flatiron Health, Infinitus, Mammoth Biosciences, Mercury, PathAI, and Presto. “In a recent Assort Health study, we uncovered that patients wait up to 35 minutes to schedule an appointment. From there, 20 million patients are booked with the wrong doctor annually in the US. Our platform is rewriting the rules, using voice AI to provide patients 24/7 access to care. 88% of appointments are booked by phone. We're not just improving the experience, we’re setting a new standard — one where every patient, no matter their background or location, receives the timely, reliable healthcare they deserve,” Jon Wang, Assort Health Co-Founder.